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In the title molecule, C11H11ClN2O, the pyrido[1,2-a]pyrimi-
dine ring system is planar (maximum deviation = 0.0148 A ˚ )
and the methyl C and carbonyl O atoms are nearly coplanar to
it. The chloroethyl side chain is in a synclinal conformation,
nearly orthogonal to the pyrimidine ring, with a dihedral angle
between the chloroethyl side chain and the pyrimidine ring of
88.5 (1) . Weak intermolecular C—H   N and C—H   Cl
hydrogen bonds along with  –  interactions between the
pyrimidine and pyridine rings [centroid–centroid distance is
3.538 (2) A ˚ ] form a three-dimensional network. The crystal is
a racemic twin with a 0.68 (12):0.32 (12) domain ratio.
MOPAC AM1 and density functional theory (DFT) theore-
tical calculations at the B3-LYP/6–311+G(d,p) level support
these observations.
Related literature
For related structures, see: Blaton et al. (1995); Chen & He
(2006); Elotmani et al. (2002); Jottier et al. (1992);
Koval’chukova et al. (2004); Peeters et al. (1993); Ravikumar
& Sridhar, (2006); Yu et al. (2007). For general background to
heterofused pyrimidines, see: Baraldi et al. (2002); Bookser et
al. (2005); Chen et al. (2004); La Motta et al. (2007); Gabbert &
Giannini (1997); Goodacre et al. (2006); Hossain et al. (1997);
Joseph & Burke (1993); Nikitin & Smirnov (1994); Sabnis &
Rangnekar (1990); Wang et al. (2004); White et al. (2004). For
the synthesis, see: Toche et al. (2008). For GAUSSIAN03
theoretical calculations, see: Becke (1988, 1993); Frisch et al.







a = 4.2546 (4) A ˚
b = 11.6274 (10) A ˚
c = 20.604 (2) A ˚
V = 1019.27 (17) A ˚ 3
Z =4
Mo K  radiation
  = 0.35 mm
 1
T = 110 K
0.51   0.35   0.12 mm
Data collection





Tmin = 0.835, Tmax = 0.959
4613 measured reﬂections
3089 independent reﬂections












 max = 0.99 e A ˚  3
 min =  0.52 e A ˚  3
Absolute structure: Flack (1983),
1103 Friedel pairs
Flack parameter: 0.32 (12)
Table 1
Hydrogen-bond geometry (A ˚ ,  ).
D—H   AD —H H   AD    AD —H   A
C5—H5A   N2
i 0.95 2.50 3.394 (3) 157
C2—H2A   Cl
ii 0.95 2.90 3.559 (3) 128
Symmetry codes: (i) x   1
2; y þ 3
2; z þ 1; (ii)  x;y þ 1
2; z þ 1
2.
Data collection: CrysAlisPro (Oxford Diffraction, 2007); cell
reﬁnement: CrysAlisPro; data reduction: CrysAlisPro; program(s)
used to solve structure: SHELXS97 (Sheldrick, 2008); program(s)
used to reﬁne structure: SHELXL97 (Sheldrick, 2008); molecular
graphics: SHELXTL (Sheldrick, 2008); software used to prepare
material for publication: SHELXTL.
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3-(2-Chloroethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
J. P. Jasinski, R. J. Butcher, Q. N. M. Hakim Al-Arique, H. S. Yathirajan and B. Narayana
Comment
Heterofused pyrimidines exhibit promising antiviral (Hossain et al. 1997), antibacterial (Sabnis & Rangnekar, 1990), anti-
AIDS (Joseph & Burke, 1993), and antinociceptive (Bookser et al. 2005) activities. Fused pyrimidines are extensively used
in neurology, particularly in the treatment of neurodegenerative disorders such as Parkinson's disease (Baraldi et al. 2002),
antianxiety disorders (Goodacre et al. 2006) and depression (Chen et al. 2004). Fused pyrimidines are selective inhibitors for
multidrug resistance (MDR) (Wang et al. 2004). A review on the synthesis, chemical and biological properties of pyrido[1,2-
a]pyrimidines is described (Nikitin & Smirnov, 1994). Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of select-
ive aldose reductase inhibitors exhibiting antioxidant activity has been reported (La Motta et al. 2007). The synthesis and
anticonvulsant evaluation of some new 2-substituted-3-arylpyrido[2,3-d]pyrimidinones have also been reported (White et
al. 2004). The crystal structures of 3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidino]ethyl}-6,7,8,9- tetrahydro-2-methyl-
4H-pyrido[1,2-a]pyrimidin-4-one (risperidone) (Peeters et al. 1993), 3-{2-[4-(4-fluorobenzoyl)piperidino]ethyl}-2-methyl-
4H-pyrido[1,2-a]pyrimidin-4-one (Pirenperone) (Blaton et al. 1995), 5-methyl-2-morpholino-3-p-tolyl-8,9,10,11-tetrahy-
dro-2-benzothieno[2', 3':6,5]pyrido[4,3-d]pyrimidin-4(3H)-one (Chen & He, 2006), 3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-
yl)-1-piperidinyl]ethyl}-2,9- dimethyl-4H-pyrido[1,2-a]pyrimidin-4-one (Ocaperidone) (Jottier et al. 1992), 2-methyl-3-
(3-methyl-1H-pyrazol-5-yl)pyrido[1,2-a]pyrimidin-4-one (Elotmani et al. 2002), 2-methyl-3-chloro-9-hydroxypyrido[1,2-
a]pyrimidin-4-one and bis(2-methyl-3-chloro-9-hydroxypyrido[1,2-a]pyrimidin-4-onium) perchlorate (Koval'chukova et
al. 2004), 3-(2-chloroethyl)-2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a] pyrimidin-1-ium chloride (Ravikumar &
Sridhar, 2006) and 9-(4-methoxybenzoyl)-1,2,3,4-tetrahydro-6H-pyrido[1,2-a]pyrimidin-6-one (Yu et al. 2007) have also
been reported.
The title compound, (I), is an intermediate in the synthesis of risperidone, which is a potent antipsychotic agent, especially
useful for treating schizophrenia (Gabbert & Giannini, 1997). In view of the importance of (I), the present paper describes
its crystal structure.
The overall molecular geometry of (I), including bond distances and angles, is in good agreement with related structures
(Blaton et al. 1995; Jottier et al. 1992; Peeters et al. 1993; Ravikumar & Sridhar, 2006). It consists of a pyridine ring fused
to a substituted pyrimidine ring creating a planar ring system (maximum deviation, C1, = -0.0148Å) with the methyl C
and carbonyl O atoms nearly coplanar to the pyrimidine ring (Torsion angles C1-C9-C7-C8 = 177.6 (3)° ; C2-N1-C1-O =
-2.5 (4)° (Fig. 1). The sum of the angles aroumd N1 is 360.0 (5)° indicating sp2 hybridization. The chloroethyl side chain
is in a synclinal (-sc) conformation (C1—C9—C10—C11 torsion angle = -86.6 (3)°), nearly orthogonal to the pyrimidine
ring, with a dihedral angle separation between the C10/C11/Cl group and the pyrimidine ring of 88.5 (1)°.
While no classic hydrogen bonds are observed, a weak intermolecular hydrogen bond interaction exists between atom
C5 from the pyridine ring and N2 from a nearby pyrimidine ring (Table 1 and Fig. 2). In addition, a weak intermolecular
interaction between atom C2 from the pyrimidine ring and Cl from the substituted pyrimidine group also occurs, each
influencing crystal packing and, therefore, resulting in a three-dimensional network (Fig. 2). In addition, π-π interactions
between N1/C1/C9/C7/N2/C6 (centroid Cg1) and N1/C2-C6 (centroid Cg2) rings of molecules at (x, y, z) and (1+x, y, z),supplementary materials
sup-2
with a Cg1···Cg2 distance of 3.538 (2) Å, provide additional stability to the crystal packing. The crystal is a racemic twin
with domains of 0.68 (12) and 0.32 (12).
In support of these observations, a MOPAC AM1 (Schmidt & Polik, 2007) and density functional theory (DFT) geometry
optimized theoretical calculation (Schmidt & Polik, 2007) with the GAUSSIAN03 program package (Frisch et al. 2004)
employing the B3-LYP (Becke 3 parameter Lee-Yang-Parr) exchange correlation functional, which combines the hybrid
exchange functional of Becke (Becke, 1988, 1993) with the gradient-correlation functional of Lee, Yang and Parr (Lee et al.
1988) and the 6–311+G(d,p) basis set (Hehre et al. 1986), was performed on (I) utilizing starting geometries taken from the
X-ray refinement data. In both calculations the resulting bond distances and angles remained relatively constant. However,
the C9—C10—C11—Cl torsion angle decreased by 3.2 (1)° to 175.4 (3)° (MOPAC) and 0.07° to 178.5 (7)° (DFT) and the
dihedral angle between the C10/C11/Cl group and the pyrimidine ring decreased by 2.3 (8)° to 86.1 (3)° (MOPAC) and by
8.3 (6)° to 80.1 (5)° (DFT), respectively.
In summary, it is clear that the collection of weak intermolecular hydrogen bond interactions and π-π intermolecular
interactions do play a role in stabilizing crystal packing of (I).
Experimental
The title compound was synthesized following the reported procedure (Toche et al. 2008). Pale yellow crystals of compound
(I) were obtained by slow evaporation from ethyl acetate solution (m.p. 405–408 K). Analytical data: Found (calculated):
C %: 59.28 (59.33); H%: 4.97 (4.98); N%: 12.54 (12.58).
Refinement
All of the H atoms were placed in their calculated positions and then refined using the riding model with C—H = 0.95–0.99
Å, and with Uiso(H) = 1.18–1.50Ueq(C).
Figures
Fig. 1. Molecular structure of (I), showing the atom labeling scheme and 50% probability dis-
placement ellipsoids.
Fig. 2. Packing diagram of (I), viewed down the b axis. Dashed lines indicate weak




C11H11ClN2O F000 = 464
Mr = 222.67 Dx = 1.451 Mg m−3
Orthorhombic, P212121 Mo Kα radiation, λ = 0.71073 Å
Hall symbol: P 2ac 2ab Cell parameters from 2755 reflections
a = 4.2546 (4) Å θ = 4.8–32.6º
b = 11.6274 (10) Å µ = 0.35 mm−1
c = 20.604 (2) Å T = 110 K
V = 1019.27 (17) Å3 Plate, colorless
Z = 4 0.51 × 0.35 × 0.12 mm
Data collection
Oxford Diffraction Gemini R CCD
diffractometer
3089 independent reflections
Radiation source: Enhance (Mo) X-ray Source 2607 reflections with I > 2σ(I)
Monochromator: graphite Rint = 0.054
Detector resolution: 10.5081 pixels mm-1 θmax = 32.6º
T = 110 K θmin = 4.9º
φ and ω scans h = −3→6
Absorption correction: multi-scan
(CrysAlis RED; Oxford Diffraction, 2007) k = −17→16
Tmin = 0.835, Tmax = 0.959 l = −30→27
4613 measured reflections
Refinement
Refinement on F2 Hydrogen site location: inferred from neighbouring
sites
Least-squares matrix: full H-atom parameters constrained
R[F2 > 2σ(F2)] = 0.065
  w = 1/[σ2(Fo
2) + (0.1108P)2 + 0.2652P]
where P = (Fo
2 + 2Fc
2)/3
wR(F2) = 0.181 (Δ/σ)max = 0.001
S = 1.11 Δρmax = 0.99 e Å−3
3089 reflections Δρmin = −0.51 e Å−3
138 parameters Extinction correction: none
Primary atom site location: structure-invariant direct
methods
Absolute structure: Flack (1983), 1103 Friedel pairs
Secondary atom site location: difference Fourier map Flack parameter: 0.32 (12)supplementary materials
sup-4
Special details
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance mat-
rix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations
between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of
cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, convention-
al R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-
factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large
as those based on F, and R- factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
x y z Uiso*/Ueq
Cl 0.49448 (19) 0.87358 (6) 0.12093 (3) 0.02056 (18)
O 0.1937 (6) 1.09071 (18) 0.30555 (10) 0.0240 (5)
N1 −0.0403 (6) 0.9961 (2) 0.39118 (10) 0.0150 (4)
N2 0.0097 (7) 0.79306 (19) 0.40322 (11) 0.0172 (4)
C1 0.1541 (7) 0.9982 (2) 0.33357 (13) 0.0151 (5)
C2 −0.1616 (9) 1.0994 (2) 0.41318 (14) 0.0207 (6)
H2A −0.1116 1.1685 0.3909 0.025*
C3 −0.3506 (8) 1.1032 (3) 0.46596 (15) 0.0231 (6)
H3A −0.4354 1.1744 0.4803 0.028*
C4 −0.4212 (7) 0.9999 (3) 0.49970 (14) 0.0211 (6)
H4A −0.5530 1.0019 0.5369 0.025*
C5 −0.3006 (8) 0.8986 (2) 0.47886 (13) 0.0191 (5)
H5A −0.3477 0.8299 0.5019 0.023*
C6 −0.1033 (7) 0.8935 (2) 0.42262 (13) 0.0147 (5)
C7 0.1973 (8) 0.7917 (2) 0.34977 (13) 0.0155 (5)
C8 0.3087 (9) 0.6735 (2) 0.33069 (16) 0.0239 (6)
H8A 0.2581 0.6188 0.3653 0.036*
H8B 0.5366 0.6750 0.3238 0.036*
H8C 0.2038 0.6499 0.2905 0.036*
C9 0.2748 (7) 0.8891 (2) 0.31499 (12) 0.0146 (5)
C10 0.4766 (9) 0.8869 (2) 0.25437 (12) 0.0182 (5)
H10A 0.6268 0.8220 0.2567 0.022*
H10B 0.5983 0.9592 0.2511 0.022*
C11 0.2671 (7) 0.8733 (3) 0.19491 (13) 0.0201 (5)
H11A 0.1130 0.9371 0.1936 0.024*
H11B 0.1489 0.8002 0.1982 0.024*
Atomic displacement parameters (Å2)
U11 U22 U33 U12 U13 U23
Cl 0.0233 (3) 0.0253 (3) 0.0132 (3) −0.0031 (3) 0.0030 (3) −0.0001 (2)
O 0.0323 (13) 0.0185 (9) 0.0214 (10) −0.0029 (9) 0.0024 (10) 0.0048 (8)supplementary materials
sup-5
N1 0.0188 (11) 0.0144 (8) 0.0118 (9) 0.0013 (9) −0.0009 (9) 0.0005 (7)
N2 0.0200 (10) 0.0157 (8) 0.0160 (10) −0.0002 (12) −0.0001 (11) 0.0019 (7)
C1 0.0168 (12) 0.0163 (11) 0.0122 (11) −0.0028 (11) −0.0005 (10) 0.0002 (9)
C2 0.0286 (15) 0.0163 (11) 0.0173 (13) 0.0039 (12) 0.0000 (12) −0.0001 (9)
C3 0.0259 (15) 0.0235 (13) 0.0198 (14) 0.0058 (13) −0.0013 (12) −0.0054 (10)
C4 0.0198 (14) 0.0300 (14) 0.0135 (12) 0.0026 (12) 0.0017 (10) −0.0019 (10)
C5 0.0196 (13) 0.0234 (12) 0.0142 (12) −0.0029 (12) 0.0018 (11) 0.0028 (10)
C6 0.0178 (11) 0.0146 (11) 0.0118 (11) −0.0013 (9) −0.0029 (9) 0.0017 (8)
C7 0.0194 (13) 0.0125 (10) 0.0146 (11) 0.0001 (11) −0.0022 (11) −0.0001 (9)
C8 0.0282 (16) 0.0167 (11) 0.0267 (15) 0.0015 (13) 0.0028 (14) −0.0022 (10)
C9 0.0133 (11) 0.0183 (11) 0.0124 (12) −0.0020 (10) −0.0004 (9) 0.0005 (9)
C10 0.0164 (12) 0.0245 (12) 0.0138 (11) −0.0008 (13) 0.0011 (10) 0.0003 (9)
C11 0.0178 (12) 0.0305 (13) 0.0119 (11) −0.0035 (12) 0.0019 (10) −0.0012 (11)
Geometric parameters (Å, °)
Cl—C11 1.805 (3) C5—C6 1.432 (4)
O—C1 1.232 (3) C5—H5A 0.95
N1—C2 1.383 (4) C7—C9 1.381 (4)
N1—C6 1.384 (3) C7—C8 1.505 (4)
N1—C1 1.447 (3) C8—H8A 0.98
N2—C6 1.325 (3) C8—H8B 0.98
N2—C7 1.360 (4) C8—H8C 0.98
C1—C9 1.421 (4) C9—C10 1.516 (4)
C2—C3 1.353 (5) C10—C11 1.523 (4)
C2—H2A 0.95 C10—H10A 0.99
C3—C4 1.420 (5) C10—H10B 0.99
C3—H3A 0.95 C11—H11A 0.99
C4—C5 1.355 (4) C11—H11B 0.99
C4—H4A 0.95
C2—N1—C6 121.5 (2) N2—C7—C8 114.0 (2)
C2—N1—C1 117.9 (2) C9—C7—C8 122.6 (3)
C6—N1—C1 120.6 (2) C7—C8—H8A 109.5
C6—N2—C7 117.9 (2) C7—C8—H8B 109.5
O—C1—C9 127.1 (3) H8A—C8—H8B 109.5
O—C1—N1 118.5 (3) C7—C8—H8C 109.5
C9—C1—N1 114.4 (2) H8A—C8—H8C 109.5
C3—C2—N1 120.9 (3) H8B—C8—H8C 109.5
C3—C2—H2A 119.5 C7—C9—C1 120.4 (2)
N1—C2—H2A 119.5 C7—C9—C10 123.3 (2)
C2—C3—C4 119.4 (3) C1—C9—C10 116.3 (2)
C2—C3—H3A 120.3 C9—C10—C11 109.5 (3)
C4—C3—H3A 120.3 C9—C10—H10A 109.8
C5—C4—C3 120.0 (3) C11—C10—H10A 109.8
C5—C4—H4A 120.0 C9—C10—H10B 109.8
C3—C4—H4A 120.0 C11—C10—H10B 109.8
C4—C5—C6 120.9 (3) H10A—C10—H10B 108.2
C4—C5—H5A 119.5 C10—C11—Cl 111.4 (2)
C6—C5—H5A 119.5 C10—C11—H11A 109.3supplementary materials
sup-6
N2—C6—N1 123.3 (2) Cl—C11—H11A 109.3
N2—C6—C5 119.6 (2) C10—C11—H11B 109.3
N1—C6—C5 117.2 (2) Cl—C11—H11B 109.3
N2—C7—C9 123.4 (2) H11A—C11—H11B 108.0
C2—N1—C1—O −2.5 (4) C4—C5—C6—N2 −179.6 (3)
C6—N1—C1—O 177.1 (3) C4—C5—C6—N1 0.5 (4)
C2—N1—C1—C9 178.7 (3) C6—N2—C7—C9 −0.1 (4)
C6—N1—C1—C9 −1.8 (4) C6—N2—C7—C8 −178.8 (3)
C6—N1—C2—C3 −0.9 (5) N2—C7—C9—C1 −1.0 (4)
C1—N1—C2—C3 178.6 (3) C8—C7—C9—C1 177.6 (3)
N1—C2—C3—C4 1.0 (5) N2—C7—C9—C10 −178.2 (3)
C2—C3—C4—C5 −0.3 (5) C8—C7—C9—C10 0.4 (5)
C3—C4—C5—C6 −0.5 (5) O—C1—C9—C7 −176.9 (3)
C7—N2—C6—N1 0.2 (4) N1—C1—C9—C7 1.8 (4)
C7—N2—C6—C5 −179.7 (3) O—C1—C9—C10 0.6 (4)
C2—N1—C6—N2 −179.7 (3) N1—C1—C9—C10 179.3 (2)
C1—N1—C6—N2 0.8 (4) C7—C9—C10—C11 90.7 (3)
C2—N1—C6—C5 0.2 (4) C1—C9—C10—C11 −86.6 (3)
C1—N1—C6—C5 −179.3 (3) C9—C10—C11—Cl 178.6 (2)
Hydrogen-bond geometry (Å, °)
D—H···A D—H H···A D···A D—H···A
C5—H5A···N2i 0.95 2.50 3.394 (3) 157
C2—H2A···Clii 0.95 2.90 3.559 (3) 128
Symmetry codes: (i) x−1/2, −y+3/2, −z+1; (ii) −x, y+1/2, −z+1/2.supplementary materials
sup-7
Fig. 1supplementary materials
sup-8
Fig. 2